Sentences with phrase «with glioblastoma multiforme»

April 2015 was a game changer for us both., Kevin was diagnosed with glioblastoma multiforme brain cancer.

April 2015 was a game changer for us both., Kevin was diagnosed with glioblastoma multiforme brain cancer.

So much so that on the day before Thanksgiving in 2006 when, at the age of 34, I was diagnosed with Glioblastoma multiforme, an incurable form of brain cancer, and told I had less than a year to live, I did what I always did: I went to school.

These preclinical studies have led to a clinical trial for patients with glioblastoma multiforme (www.clinicaltrials.gov NCT02046187).

The researchers are currently enrolling patients with stage 4 lung cancer and will soon begin enrolling people with glioblastoma multiforme (brain cancer) in these phase II trials.

The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.

This compares with 14 months for patients with glioblastoma multiforme — a complex and aggressive astrocytoma.

Most people with glioblastoma multiforme die within a year of diagnosis, as standard treatments can not eradicate these tumours.

For patients with glioblastoma multiforme, the vaccine did not seem to prevent the recurrence of cancer, so those patients were offered follow - up chemotherapy.

The investigators report that trapping virus - loaded stem cells in a gel and applying them to tumors significantly improved survival in mice with glioblastoma multiforme, the most common brain tumor in human adults and also the most difficult to treat.

The former Labour cabinet minister who was diagnosed with a glioblastoma multiforme brain tumour in May last year, suffered a haemorrhage on Friday, and had been in a coma until her death on Saturday, a spokesman for the family said.

Not exact matches

Glioblastoma multiforme is the most common and aggressive form of brain cancer, with a median survival of about 15 months.

Trial # 1: A phase I / II trial of HCQ in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme

This guarded optimism is based on the phase I trial data showing an increase in overall survival of 4 - 6 months in 11 glioblastoma multiforme patients (18 - 22 months) versus the 14 - 16 months survival typically seen with the standard treatment.

Patients with recurrent glioblastoma multiforme (GBM) treated with an experimental vaccine made from the patient's own resected tumor tissue showed an improved survival compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine that was recently published in the journal Neuro - Oncology and accompanied by an editorial highlighting the importance of the trial.

A phase I / II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.

Whereas, a phase I / II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme led to no significant improvement in overall survival, which could be due to inconsistent autophagy inhibition in patients treated with this regimen [29].

Glioblastoma multiforme (GBM) is considered the most malignant of primary brain cancers with only about 12 % of patients living beyond 36 months (long - term survivors).

A 65 - year old woman who was suffering from glioblastoma multiforme (GBM), an aggressive type of brain cancer, was put into a restricted ketogenic diet that started with water fasting and then proceeded to consume 600 calories a day only.

Calorie restriction has been used effectively to treat malignant glioblastoma multiforme in mice, which shares many characteristics with human glioblastoma multiforme, the most aggressive and invasive primary human brain cancer [3].

California State University, Fullerton About Blog This blog captures the experiences with Darrell's glioblastoma multiforme (GBM).

Background ImmunoCellular Therapeutics is a California - based oncology firm with the lead candidate ICT - 107 entering Phase II for patients with a particular form of brain cancer, glioblastoma multiforme (GBM).

California State University, Fullerton About Blog This blog captures the experiences with Darrell's glioblastoma multiforme (GBM).

California State University, Fullerton About Blog This blog captures the experiences with Darrell's glioblastoma multiforme (GBM).

California State University, Fullerton About Blog This blog captures the experiences with Darrell's glioblastoma multiforme (GBM).